Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 8Colorectal Neoplasms 8Colonic Neoplasms 4Stomach Neoplasms 3Thrombocytopenia 1Pancreatic Neoplasms 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1Mesothelioma, Malignant 1Inoperable Esophageal Cancer Stage I-III 1Hepatecellular Carcinoma 1Fruquintinib 1Esophageal Squamous Cell Carcinoma 1Advanced Metastatic Colorectal Cancer 1Advanced Gastric Cancer 1Advanced Colorectal Carcinoma 1Advanced Colorectal Cancer 1

Interventions

raltitrexed 1Irinotecan 1Cetuximab 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Advanced Metastatic Colorectal Cancer × raltitrexed × Clear all
NCT05160896 2023-06-08

SALIRI Based Regimen as First-line Treatment for Advanced Metastatic Colorectal Cancer

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 2 Unknown
90 enrolled
Gastrointestinal

Advanced Metastatic Colorectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡